Iron Supplementation Using Total Dose Infusion and Oral Routes for Treatment of Iron Deficiency Anemia in Pregnancy

• Status: Completed
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Evaluate the effect of iron supplementation using oral routes in comparison with total dose infusion of low molecular weight iron dextran in iron deficiency anemia during pregnancy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University
• Treatments: Dextrans; Hematinics; Iron; Iron-Dextran Complex

Criteria

Inclusion Criteria:

• Maternal age 20-35 years old.

• Singleton pregnancy between 16 - 24 weeks.

• Iron deficiency anemia with average hemoglobin ranging from 7-9 g % at the onset of the study.

Exclusion Criteria:

• Extremes of reproductive age (less than 20 years old or more than 35 years old).

• Patients with multiple pregnancies.

• Anemia not linked to iron deficiency.

• Allergy to iron derivatives.

• Any medical disorder like diabetes or tuberculosis (TB), viral hepatitis cirrhosis, cardiovascular disease, renal disease, autoimmune disease, suspected acute infection, cancer.

• Those who had received parenteral iron treatment earlier within 3 months before the start of the study.

• Any obstetric complicating factors like pregnancy induced hypertension.

• Patients with history of chronic blood loss.